Why Drug Companies Prefer Vaccines Over Treatments for Profit

Dr. Peter McCullough argues that drug companies favor vaccines over treatments due to profit potential. A universal vaccine could reach 300 million people, while a treatment might only serve 50,000, highlighting a financial incentive in public health strategies.

AI-generated summary — may contain errors. How it works